Programme providers charge more but include registered dietitian support, behavioural coaching, and strategies for maintaining results over the long term
reports speaking honoraria and/or consulting fees from Abbott, AstraZeneca, Bayer, Boehringer Ingelheim, Novo Nordisk, Novartis, Merck, PhaseBio, HLS Therapeutics, Amarin, Eli Lilly, Janssen, Pfizer, TIMI, Canadian Medical and Surgical Knowledge Translation Research Group
A partir de un punto de referencia de peso de 210 lb., Mounjaro redujo en promedio el peso de los participantes en 12 lb.* (5 mg), 17 lb.* (10 mg) y 19 lb.* (15 mg) al compararlo con un aumento de 4 lb
About the SYNCHRONIZE-1 trial (NCT06066515) This is a Phase III, double-blind, placebo-controlled 76-week efficacy and safety trial of survodutide among 725 adults living with obesity or overweight, without type 2 diabetes